Zobrazeno 1 - 10
of 35
pro vyhledávání: '"MESH : Glucagon"'
Autor:
Vincent W.S. Wong, Shira Zelber‐Sagi, Kenneth Cusi, Patrizia Carrieri, Eugene Wright, Javier Crespo, Jeffrey V. Lazarus
Publikováno v:
Liver International
Liver International, 2022, 42 (11), pp.2377-2389. ⟨10.1111/liv.15404⟩
Liver International, 2022, 42 (11), pp.2377-2389. ⟨10.1111/liv.15404⟩
Non-alcoholic fatty liver disease (NAFLD) affects at least 25% of the general population and is an increasingly important cause of cirrhosis and hepatocellular carcinoma. Although it is the research focus of the hepatology field, it is clear that pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58808da3ed3152caa1fb70ff81312d15
https://www.hal.inserm.fr/inserm-04051853/document
https://www.hal.inserm.fr/inserm-04051853/document
Autor:
Nancy Antoine, Lucie Ruiz, Holger Klein, Patrick Gilon, Anne Wojtusciszyn, Fiona M. Gribble, Frank Reimann, Robert Augustin, Bao-Khanh Lai, Bilal Singh, Michael P. Pieper, Eva Gatineau, Nano Rita, Mohammed Bensellam, Pedro Luis Herrera, Birgit Stierstorfer, Firas Khattab, Heeyoung Chae, Lorenzo Piemonti, Davide Brusa, Michael Mark, Eric Mayoux, Christophe Broca
Publikováno v:
Molecular Metabolism
Molecular metabolism, vol. 42, pp. 101071
Molecular metabolism
Molecular metabolism, Elsevier, 2020, 42, pp.101071. ⟨10.1016/j.molmet.2020.101071⟩
Molecular Metabolism (2020) P. 101071
Molecular Metabolism, Vol 42, Iss, Pp 101071-(2020)
Molecular metabolism, vol. 42, pp. 101071
Molecular metabolism
Molecular metabolism, Elsevier, 2020, 42, pp.101071. ⟨10.1016/j.molmet.2020.101071⟩
Molecular Metabolism (2020) P. 101071
Molecular Metabolism, Vol 42, Iss, Pp 101071-(2020)
Objective Sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, are anti-diabetic drugs that lower glycemia by promoting glucosuria, but they also stimulate endogenous glucose and ketone body production. The likely causes of thes
Publikováno v:
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Wiley, 2020, 46 (4), pp.261-264. ⟨10.1016/j.diabet.2020.01.004⟩
Endocrinology, Diabetes & Metabolism, Wiley, 2020, 46 (4), pp.261-264. ⟨10.1016/j.diabet.2020.01.004⟩
International audience; Therapeutic efficiency of Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs) is generally assessed from Randomized Controlled Trials (RCTs) by comparing primary or secondary outcomes in persons with a specific disease, havin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeaed005b43763ee7629d2a2b7f0ea5c
https://hal.umontpellier.fr/hal-03508727
https://hal.umontpellier.fr/hal-03508727
Autor:
Pierre Cattan, Julien Castel, Rémy Burcelin, Aurélie Waget, Daniel J. Drucker, Mattieu Armanet, Melis Karaca, Christophe Magnan, Jens J. Holst, Céline Garret, Thierry Sulpice, Gaëlle Payros, Myriam Masseboeuf, Adriano Maida, Cendrine Cabou
Publikováno v:
Endocrinology
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. 〈10.1210/en.2011-0286〉
Endocrinology, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. 〈10.1210/en.2011-0286〉
Endocrinology, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩
International audience; Inhibition of dipeptidyl peptidase-4 (DPP-4) activity improves glucose homeostasis through a mode of action related to the stabilization of the active forms of DPP-4-sensitive hormones such as the incretins that enhance glucos
Autor:
Sylvie Dejager, Rémy Burcelin
Publikováno v:
Diabetes & Metabolism
Diabetes & Metabolism, 2010, 36 (6 Pt 1), pp.503-9. ⟨10.1016/j.diabet.2010.09.002⟩
Diabetes & Metabolism, 2010, 36 (6 Pt 1), pp.503-9. ⟨10.1016/j.diabet.2010.09.002⟩
International audience; Over the past 2 years, more than 1300 manuscripts have been published on glucagon-like peptide-1 (GLP-1) and yet, what do we know about it for sure? The European Club for the Study of GLP-1 (EuCSGLP-1) has debated the latest c
Autor:
Kirk M. Habegger, Fa Liu, Dominik Lutter, Richard D. DiMarchi, Marc E. Healy, Maximilian Kleinert, Heike Biebermann, Yvonne Döring, Diego Perez-Tilve, Katrin Fischer, Luisa Müller, Peng Liu, Achim Weber, Susanna M. Hofmann, Christian Weber, Martin Jastroch, Frédéric Flamant, Miguel A. Sánchez-Garrido, Karl-Werner Schramm, Helmut Fuchs, Valerie Gailus-Durner, Brian Finan, Jan Rozman, Mohsen Malehmir, Sigrid Jall, Matthias H. Tschöp, Martin Hrabě de Angelis, Kerstin Stemmer, Josef Köhrle, Christoffer Clemmensen, Bin Yang, Meri De Angelis, Timo D. Müller, Sara J. Brandt, Zhimeng Zhu, Michaela Keuper, Vasily M. Gelfanov, Mathias Heikenwalder, Kristin Moreth, Frauke Neff, Jan Tuckermann, Karine Gauthier
Publikováno v:
Cell
Cell, Elsevier, 2016, 167 (3), pp.843-857. ⟨10.1016/j.cell.2016.09.014⟩
Cell, Elsevier, 2016, 167 (3), pp.843-857.e14. ⟨10.1016/j.cell.2016.09.014⟩
Cell 167, 843-857.e14 (2016)
Cell, 167(3), 843-857. Cell Press
Cell, 2016, 167 (3), pp.843-857.e14. ⟨10.1016/j.cell.2016.09.014⟩
Cell, Elsevier, 2016, 167 (3), pp.843-857. ⟨10.1016/j.cell.2016.09.014⟩
Cell, Elsevier, 2016, 167 (3), pp.843-857.e14. ⟨10.1016/j.cell.2016.09.014⟩
Cell 167, 843-857.e14 (2016)
Cell, 167(3), 843-857. Cell Press
Cell, 2016, 167 (3), pp.843-857.e14. ⟨10.1016/j.cell.2016.09.014⟩
International audience; Glucagon and thyroid hormone (T3) exhibit therapeutic potential for metabolic disease but also exhibit undesired effects. We achieved synergistic effects of these two hormones and mitigation of their adverse effects by enginee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d42eda11b0af6ca1dd39246d570e3a
https://hal.archives-ouvertes.fr/hal-01607311
https://hal.archives-ouvertes.fr/hal-01607311
Autor:
Evan D. Rosen, Jianxin Xie, Chen-Yu Zhang, Annie Ladoux, Hao Zhu, Susumu Ito, Edward H. Leiter, Michelle Chu, H. Franklin Bunn, Kevin Larade, Ayden Seguritan, Roderick T. Bronson
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2004, 101 (29), pp.10750-5. ⟨10.1073/pnas.0404044101⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2004, 101 (29), pp.10750-5. ⟨10.1073/pnas.0404044101⟩
NCB5OR is a highly conserved NAD(P)H reductase that contains a cytochrome b5-like domain at the N terminus and a cytochrome b5 reductase-like domain at the C terminus. The enzyme is located in the endoplasmic reticulum (ER) and is widely expressed in
Publikováno v:
Biochemical Society Transactions
Biochemical Society Transactions, 2001, 29 (4), pp.547-552. ⟨10.1042/bst0290547⟩
Biochemical Society Transactions, Portland Press, 2001, 29 (4), pp.547-552. ⟨10.1042/bst0290547⟩
Biochemical Society Transactions, 2001, 29 (4), pp.547-552. ⟨10.1042/bst0290547⟩
Biochemical Society Transactions, Portland Press, 2001, 29 (4), pp.547-552. ⟨10.1042/bst0290547⟩
Effects of insulin on the expression of liver-specific genes are part of the adaptive mechanisms aimed at maintaining energy homeostasis in mammals. When the diet is rich in carbohydrates, secreted insulin stimulates the expression of genes for enzym
Publikováno v:
FEBS Letters
FEBS Letters, Wiley, 2006, 580 (24), pp.5697-704. ⟨10.1016/j.febslet.2006.09.021⟩
FEBS Letters, 2006, 580 (24), pp.5697-704. ⟨10.1016/j.febslet.2006.09.021⟩
FEBS Letters, Wiley, 2006, 580 (24), pp.5697-704. 〈10.1016/j.febslet.2006.09.021〉
FEBS Letters, Wiley, 2006, 580 (24), pp.5697-704. ⟨10.1016/j.febslet.2006.09.021⟩
FEBS Letters, 2006, 580 (24), pp.5697-704. ⟨10.1016/j.febslet.2006.09.021⟩
FEBS Letters, Wiley, 2006, 580 (24), pp.5697-704. 〈10.1016/j.febslet.2006.09.021〉
To assess glucagon receptor compartmentalization and signal transduction in liver parenchyma, we have studied the functional relationship between glucagon receptor endocytosis, phosphorylation and coupling to the adenylate cyclase system. Following a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadde96ea9bd99d4f1bfa6d69df9344c
https://www.hal.inserm.fr/inserm-00175470
https://www.hal.inserm.fr/inserm-00175470
Publikováno v:
Biochemical Society Transactions
Biochemical Society Transactions, 2001, pp.547-52
Biochemical Society Transactions, Portland Press, 2001, pp.547-52
Biochemical Society Transactions, 2001, pp.547-52
Biochemical Society Transactions, Portland Press, 2001, pp.547-52
International audience; Effects of insulin on the expression of liver-specific genes are part of the adaptive mechanisms aimed at maintaining energy homeostasis in mammals. When the diet is rich in carbohydrates, secreted insulin stimulates the expre